Tenaya Therapeutics
TNYA
107 hedge funds and large institutions have $27.7M invested in Tenaya Therapeutics in 2025 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 22 increasing their positions, 33 reducing their positions, and 10 closing their positions.
200% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 10
133% more call options, than puts
Call options by funds: $126K | Put options by funds: $54K
22% more funds holding
Funds holding: 88 → 107 (+19)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23.99% less ownership
Funds ownership: 55.51% → 31.52% (-24%)
33% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 33
56% less capital invested
Capital invested by funds: $62.8M → $27.7M (-$35.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$5.82M |
| 2 |
Renaissance Technologies
New York
|
+$1.52M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$799K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$765K |
| 5 |
Two Sigma Investments
New York
|
+$319K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$2.86M |
| 2 |
Morgan Stanley
New York
|
-$1.16M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$433K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$221K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$206K |
TNYA Hedge Fund Activity: Q1 2025 in Review
107 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q1 2025, worth a combined $27.7M — down 56% from $62.8M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new TNYA positions and 10 closed out — a net gain of 20 holders — while 22 added to existing stakes and 33 trimmed.
The largest buyer was Woodline Partners, adding an estimated $5.82M. The largest seller was JP Morgan Chase, cutting an estimated $2.86M.
- 107 institutional investors held Tenaya Therapeutics (TNYA) as of Q1 2025, up from 88 in Q4 2024.
- Funds reported $27.7M of Tenaya Therapeutics stock for Q1 2025, down 56% quarter-over-quarter.
- 30 funds opened new Tenaya Therapeutics positions in Q1 2025 and 10 closed out, a net change of +20 holders.
- The largest Tenaya Therapeutics buyer in Q1 2025 was Woodline Partners, an estimated $5.82M added.
- The largest Tenaya Therapeutics seller in Q1 2025 was JP Morgan Chase, an estimated $2.86M sold.
Based on aggregated 13F filings for Q1 2025.